  | Pirson, S.* , Gautier-Isola, M.* , Baudin, L., Rouaud, L., Vanwynsberghe, A., Deroye, J., Bekisz, S., Gucciardo, F., LEBEAU, A., Buntinx, F., Ivanova, E., Staumont, B., Blacher, S., Gilles, C.* , & Noël, A.*. (27 February 2025). AXL promotes lymphangiogenesis by amplifying VEGF-C-mediated AKT pathway. Cellular and Molecular Life Sciences, 82 (1), 95. doi:10.1007/s00018-024-05542-3  Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
Wuidar, V., Dias Da Silva, I., Zielonka, M., Flas, C., Staumont, B., & Pequeux, C. (29 January 2025). Transient Activation of ERα by Pulsed Estrogen Treatments Prevent the Growth of Breast Cancer [Poster presentation]. Séminaire Télévie 2025, Liège, Belgium. |
 | Staumont, B., Maia Ladeira, L. C., Gamba, A., Heusinkveld, H. J., Piersma, A., Fritsche, E., Masereeuw, R., Vanhaecke, T., Teunis, M., Luechtefeld, T., Hartung, T., Jover, R., Vinken, M., & Geris, L. (2025). Mapping physiology: a systems biology approach for the development of alternative methods in toxicology. ALTEX: Alternatives to Animal Experimentation. doi:10.14573/altex.2412241 Editorial reviewed |
 | Maia Ladeira, L. C., Verhoeven, A., van Ertvelde, J., Jiang, J., Gamba, A., Sanz Serrano, J., Vanhaecke, T., Heusinkveld, H. J., Jover, R., Vinken, M., Geris, L., & Staumont, B. (2024). Unlocking liver physiology: comprehensive pathway maps for mechanistic understanding. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/327181. doi:10.5281/zenodo.14515238 |
 | Niarakis, A., Laubenbacher, R., An, G., Ilan, Y., Fisher, J., Flobak, Å., Reiche, K., Rodríguez Martínez, M., Geris, L., Maia Ladeira, L. C., Veschini, L., Blinov, M. L., Messina, F., Fonseca, L. L., Ferreira, S., Montagud, A., Noël, V., Marku, M., Tsirvouli, E., ... Glazier, J. A. (30 November 2024). Immune digital twins for complex human pathologies: applications, limitations, and challenges. NPJ Systems Biology and Applications, 10 (1), 141. doi:10.1038/s41540-024-00450-5 Peer Reviewed verified by ORBi |
 | Messina, F., Rotondo, C., Maia Ladeira, L. C., Properzi, M., Dimartino, V., Riccitelli, B., Staumont, B., Chilemi, G., Geris, L., Bocci, M. G., & Fontana, C. (2024). Building a model of sepsis: data integration unravels pathogenic mechanisms in severe P. aeruginosa infections. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/327015. doi:10.1101/2024.10.17.618881 |
Wuidar, V., Dias Da Silva, I., Zielonka, M., Flas, C., Staumont, B., & Pequeux, C. (23 September 2024). Prevention of Breast Cancer Growth: A Complex Interplay Between Estrogen Receptor Activation and Estrogen Nature [Poster presentation]. EMBO Workshop: Nuclear Receptors: No Disease is Safe, Cavtat, Croatia. |
  | Gamba, A., Maia Ladeira, L. C., Barnes, D. A., Janssen, M. J., Masereeuw, R., Geris, L., & Staumont, B. (September 2024). P05-50 Using ontology map and physiological map to improve predictive models for kidney toxicity. Toxicology Letters, 399, 151-S152. doi:10.1016/j.toxlet.2024.07.385 Peer Reviewed verified by ORBi |
 | Maia Ladeira, L. C., Mazein, A., Ostaszewski, M., Verhoeven, A., Kuchovská, E., Sanz-Serrano, J., Drees, A., Reiche, K., Sewald, K., Fritsche, E., Vinken, M., Geris, L., & Staumont, B. (September 2024). OS02-03 Using a systems biology approach to construct adverse outcome pathway networks aligned with the FAIR principles. Toxicology Letters, 399, 58. doi:10.1016/j.toxlet.2024.07.164 Peer Reviewed verified by ORBi |
 | Maia Ladeira, L. C., Staumont, B., Gamba, A., & Geris, L. (2024). ONTOX's Physiological Maps Curation Guidelines. doi:10.5281/zenodo.13239453 |
 | Kuchovska, E., Maia Ladeira, L. C., Bartmann, K., Polozij, D., Gorts, N., Corek, E., Donmez, A., Saborowski, L.-C., Bendt, F., Schade, M., Raad, G., Gamba, A., Staumont, B., Bal-Price, A., Wojewodzic, M., Lislien, M., Impelizzeri, A., Hofer, T., Dirven, H., ... Fritsche, E. (September 2024). S05-01 Functional mapping of neurodevelopmental disorders to ontology-based DNT NAMs for Next Generation Risk Assessment of chemicals. Toxicology Letters, 399, 18. doi:10.1016/j.toxlet.2024.07.056 Peer Reviewed verified by ORBi |
 | Staumont, B., Maia Ladeira, L. C., Gamba, A., Verhoeven, A., Serrano, J. S., Kuchovska, E., Berkhout, J., A., D., Teunis, M., Luechtefeld, T. H., Hartung, T., Jover, R., Vanhaecke, T., Fritsche, E., Heusinkveld, H. J., Piersma, A., Masereeuw, R., Vinken, M., & Geris, L. (September 2024). P05-45 Ontology maps: data integration tools for applications in toxicology. Toxicology Letters, 399, 149-S150. doi:10.1016/j.toxlet.2024.07.380 Peer Reviewed verified by ORBi |
Dias Da Silva, I., Wuidar, V., Staumont, B., Nisolle, M., & Pequeux, C. (10 May 2024). Deciphering the molecular signaling of estrogenic treatments and their analogues on the human endometrium for safer hormonal treatments [Poster presentation]. Gynecological Endocrinology - the 21th World Congress, Florence, Italy. |
Pirson, S., Gautier, M., Baudin, L., Rouaud, L., Vanwynsberghe, A., Deroye, J., Bekisz, S., Gucciardo, F., Lebeau, A., Staumont, B., Blacher, S., Gilles, C., & Noël, A. (05 March 2024). AXL promotes lymphangiogenesis by amplifying VEGF-C-mediated PI3K/AKT pathway [Poster presentation]. Gordon Research Conference and Seminar on Lymphatics, Ventura, United States - California. |
Staumont, B., Maia Ladeira, L. C., Gamba, A., Verhoeven, A., Sanz-Serrano, J., Kuchovska, E., Berkhout, J., Barnes, D. A., Janssen, M. J., Teunis, M., Luechtefeld, T. H., Hartung, T., Jover, R., Vanhaecke, T., Fritsche, E., Heusinkveld, H. J., Piersma, A., Masereeuw, R., Vinken, M., & Geris, L. (2024). Mapping Physiology As A Basis For Building Disease Ontology Maps. In 22ND INTERNATIONAL CONGRESS ESTIV BOOK OF ABSTRACTS. ESTIV. Peer reviewed |
Staumont, B., Maia Ladeira, L. C., Gamba, A., Verhoeven, A., Sanz-Serrano, J., Kuchovska, E., Berkhout, J., Barnes, D. A., Teunis, M., Luechtefeld, T., Hartung, T., Jover, R., Vanhaecke, T., Fritsche, E., Heusinkveld, H. J., Piersma, A., Masereeuw, R., Vinken, M., & Geris, L. (2024). From physiological maps to disease ontology maps using a systems biology approach. In Book of Abstracts. 3rd Annual Meeting of the ONTOX Project. ZENODO. Peer reviewed |
Maia Ladeira, L. C., Mazein, A., Ostaszewski, M., Verhoeven, A., Sanz-Serrano, J., Drees, A. H., Vanhaecke, T., Vinken, M., Geris, L., & Staumont, B. (March 2024). Semi-automated workflow to accelerate AOP network construction using SBGN elements: a pilot study [Paper presentation]. 8th Disease Maps Community Meeting. Peer reviewed |
Staumont, B., Maia Ladeira, L. C., Gamba, A., Verhoeven, A., Sanz-Serrano, J., Kuchovska, E., Berkhout, J., Barnes, D. A., Teunis, M., Luechtefeld, T., Hartung, T., Jover, R., Vanhaecke, T., Fritsche, E., Heusinkveld, H. J., Piersma, A., Masereeuw, R., Vinken, M., & Geris, L. (2024). Building disease ontology maps: in silico tools for applications in toxicology. In VPH Conference 2024 Book of Abstracts. VPH2024. Peer reviewed |
 | Berkhout, J. H., Piersma, A., Legler, J., Gamba, A., Maia Ladeira, L. C., Staumont, B., Lesage, R., Geris, L., Knudsen, T. B., Spencer, R. M., & Heusinkveld, H. J. (September 2023). P06-05: Towards a virtual embryo: Computational modelling of neural tube closure defects. Toxicology Letters, 384, 106. doi:10.1016/s0378-4274(23)00510-6 Peer Reviewed verified by ORBi |
 | Gamba, A., Maia Ladeira, L. C., Lesage, R., Barnes, D. A., Janssen, M. J., Teunis, M., Masereeuw, R., Geris, L., & Staumont, B. (September 2023). P06-36: The nephron physiological map as a tool to build kidney disease ontologies. Toxicology Letters, 384, 119. doi:10.1016/s0378-4274(23)00539-8 Peer Reviewed verified by ORBi |
 | Maia Ladeira, L. C., Kuchovská, E., Görts, N., Hofer, T., Myhre, O., Lopez Soop, G. L. S., Dirven, H., Gamba, A., Lesage, R., Fritsche, E., Geris, L., & Staumont, B. (September 2023). LP-24: The Cognitive Function Defects Ontology: Integrating Biological, Toxicological, and Chemical Data for Next-Generation Risk Assessment. Toxicology Letters, 384, 316-S317. doi:10.1016/s0378-4274(23)00989-x Peer Reviewed verified by ORBi |
 | Kuchovska, E., Bartmann, K., Maia Ladeira, L. C., Dönmez, A., Saborowski, L.-C., Bendt, F., Schade, M., Raad, G., Lesage, R., Gamba, A., Staumont, B., Geris, L., & Fritsche, E. (September 2023). P22-35: Mapping of DNT NAMs’ signaling pathways in human physiology and disease for regulatory application. Toxicology Letters, 384, 264. doi:10.1016/s0378-4274(23)00868-8 Peer Reviewed verified by ORBi |
Pirson, S., Gautier, M., Baudin, L., Rouaud, L., Vanwynsberghe, A., Deroye, J., Bekisz, S., Gucciardo, F., Lebeau, A., Staumont, B., Blacher, S., Gilles, C., & Noël, A. (14 June 2023). Identification of a new actor involved in lymphangiogenesis processes [Poster presentation]. Lymphatic Forum 2023, Banff, Canada. |
 | Kuchovska, E., Gamba, A., Maia Ladeira, L. C., Staumont, B., Lesage, R. L., Steffensen, I.-L., Soop, G. L., Hofer, T., Myhre, O., Dirven, H., Geris, L., & Fritsche, E. (24 November 2022). FIRST STEPS FOR CREATING AN ONTOLOGY FOR COGNITIVE FUNCTION DEFECTS FOR REGULATORY APPLICATION [Poster presentation]. 21st International Congress ESTIV, Sitges, Spain. Editorial reviewed |
 | Maia Ladeira, L. C.* , Gamba, A.* , Lesage, R., Kuchovska, E., Görts, N., Verhoeven, A., Jiang, J., van Ertvelde, J., Barnes, D., Janssen, M., Berkhout, J., Roodzant, D., Teunis, M., Bozada, T. J., Luechtefeld, T., Jover, R., Vanhaecke, T., Vinken, M., Masereeuw, R., ... Staumont, B. (24 November 2022). Physiological maps and chemical-induced disease ontologies: tools to support NAMs development for next-generation risk assessment [Poster presentation]. ASPIS Open Symposium, Sitges, Spain. Editorial reviewed* These authors have contributed equally to this work. |
 | Pappalardo, F., Wilkinson, J., Busquet, F., Bril, A., Palmer, M., Walker, B., Curreli, C., Russo, G., Marchal, T., Toschi, E., Alessandrello, R., Costignola, V., Klingmann, I., Contin, M., Staumont, B., Woiczinski, M., Kaddick, C., Salvatore, V. D., Aldieri, A., ... Viceconti, M. (November 2022). Toward A Regulatory Pathway for the Use of in Silico Trials in the CE Marking of Medical Devices. IEEE Journal of Biomedical and Health Informatics, 26 (11), 5282-5286. doi:10.1109/JBHI.2022.3198145 Peer Reviewed verified by ORBi |
 | Maia Ladeira, L. C., Gamba, A., Lesage, R. L., Verhoeven, A., van Ertvelde, J., Jiang, J., Roodzant, D. L., Teunis, M., Jover, R., Vanhaecke, T., Vinken, M., Heuseinkveld, H., Geris, L., & Staumont, B. (2022). Designing physiological maps as a tool to study liver toxicology. In Helena Kandarova & João Barroso, 21st International Congress ESTIV Abstract Book. Bratslava, Slovakia: ESTIV. Editorial reviewed |
 | Gamba, A., Maia Ladeira, L. C., Lesage, R., Roodzant, D., Barnes, D., Janssen, M., Teunis, M., Masereeuw, R., Geris, L., & Staumont, B. (20 October 2022). Physiological map to study kidney toxicity in the ONTOX project [Poster presentation]. 21st International Congress ESTIV, Sitges, Spain. Editorial reviewed |
 | Barnes, D., Irvine, A., Gamba, A., Maia Ladeira, L. C., Staumont, B., Yang, H., Steffensen, I.-L., Geris, L., Janssen, M., & Masereeuw, R. (2022). Development of an adverse outcome pathway for kidney tubular necrosis. In Helena Kandarova & João Barroso, 21st International Congress ESTIV Abstract Book. Bratslava, Slovakia: ESTIV. Editorial reviewed |
 | Berkhout, J., Piersma, A., Legler, J., Gamba, A., Maia Ladeira, L. C., Staumont, B., Lesage, R. L., Geris, L., & Heuseinkveld, H. (2022). Computational modelling of neural tube closure defects. In Helena Kandarova & João Barroso, 21st International Congress ESTIV Abstract Book. Bratslava, Slovakia: ESTIV. Editorial reviewed |
 | Maia Ladeira, L. C., Gamba, A., Lesage, R. L., Verhoeven, A., Jiang, J., van Ertvelde, J., Jover, R., Vanhaecke, T., Mathieu, V., Geris, L., & Staumont, B. (2022). Developing a physiological map as a framework to study chemical- induced liver steatosis. In VPHi, VPH2022 Virtual Physiological Human Conference. Brussels, Belgium: VPHi. Editorial reviewed |
 | Gamba, A., Maia Ladeira, L. C., Lesage, R. L., Roodzant, D. L., Barnes, D. A., Janssen, M. J., Teunis, M., Masereeuw, R., Geris, L., & Staumont, B. (2022). From Physiological Map to Ontology Unravelling Kidney Toxicity From Physiological Map to Ontology Unravelling Kidney Toxicity. In VPHi, VPH2022 Virtual Physiological Human Conference. Brussels, Belgium: VPHi. Editorial reviewed |
 | Maia Ladeira, L. C., Gamba, A., Lesage, R., Ertvelde, J. V., Jiang, J., Verhoeven, A., Roodzant, D., Teunis, M., Jover, R., Vanhaecke, T., Vinken, M., Geris, L., & Staumont, B. (September 2022). P11-09 Physiology-based framework to study chemical-induced cholestasis. Toxicology Letters, 368, 165-S166. doi:10.1016/j.toxlet.2022.07.459 Peer Reviewed verified by ORBi |
 | Kuchovska, E., Gamba, A., Maia Ladeira, L. C., Staumont, B., Lesage, R., Steffensen, I.-L., Soop, G. L., Hofer, T., Myhre, O., Dirven, H., Geris, L., & Fritsche, E. (September 2022). SOC-II-09 First steps for creating an ontology for cognitive function defects for regulatory application. Toxicology Letters, 368, 35-S36. doi:10.1016/j.toxlet.2022.07.112 Peer Reviewed verified by ORBi |
 | Staumont, B., Maia Ladeira, L. C., Gamba, A., Lesage, R., Verhoeven, A., Jiang, J., Ertvelde, J. V., Barnes, D. A., Janssen, M. J., Kuchovska, E., Berkhout, J., Roodzant, D., Teunis, M., Bozada, T., Luechtefeld, T. H., Jover, R., Vanhaecke, T., Vinken, M., Masereeuw, R., ... Geris, L. (September 2022). SOC-VI-08 Physiological maps: a benchmark tool for adverse outcome pathways and a cornerstone for the development of disease ontologies. Toxicology Letters, 368, 77-S78. doi:10.1016/j.toxlet.2022.07.228 Peer Reviewed verified by ORBi |
 | Barnes, D., Irvine, A., Gamba, A., Staumont, B., Maia Ladeira, L. C., Yang, H., Steffensen, I.-L., Geris, L., Janssen, M., & Masereeuw, R. (September 2022). P01-07 Development of an adverse outcome pathway for kidney tubular necrosis. Toxicology Letters, 368, 86-S87. doi:10.1016/j.toxlet.2022.07.251 Peer Reviewed verified by ORBi |
 | Gamba, A., Maia Ladeira, L. C., Lesage, R., Barnes, D. A., Roodzant, D., Teunis, M., Janssen, M. J., Masereeuw, R., Geris, L., & Staumont, B. (2022). P04-06 New approaches for evaluating kidney toxicity using physiological maps. Toxicology Letters. doi:10.1016/j.toxlet.2022.07.290 Peer Reviewed verified by ORBi |
 | Corradi, M. P. F., de Haan, A. M., Staumont, B., Piersma, A. H., Geris, L., Pieters, R. H. H., Krul, C. A. M., & Teunis, M. A. T. (August 2022). Natural language processing in toxicology: Delineating adverse outcome pathways and guiding the application of new approach methodologies. Biomaterials and Biosystems, 7, 100061. doi:10.1016/j.bbiosy.2022.100061 Peer Reviewed verified by ORBi |
 | Staumont, B., Jamakhani, M., Costa, C., Vandermeers, F., Sriramareddy, S. N., Redouté, G., Mascaux, C., Delvenne, P., Hubert, P., Safari, R., & Willems, L. (2020). TGFα Promotes Chemoresistance of Malignant Pleural Mesothelioma. Cancers, 12 (6), 1484. doi:10.3390/cancers12061484 Peer Reviewed verified by ORBi |
 | Briand, M.-M., Gosseries, O., Staumont, B., Laureys, S., & Thibaut, A. (2020). Transcutaneous Auricular Vagal Nerve Stimulation and Disorders of Consciousness: A Hypothesis for Mechanisms of Action. Frontiers in Neurology, 11. doi:10.3389/fneur.2020.00933 Peer Reviewed verified by ORBi |
 | Staumont, B. (2017). New therapeutic approaches for malignant pleural mesothelioma targeting DNA repair and transforming growth factor TGF-alpha [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/216345 |
Staumont, B. (09 March 2017). Study of the mechanisms involved in the resistance to malignant pleural mesothelioma chemo and radio-therapies [Paper presentation]. GIGA-Cancer seminar. |
Staumont, B., Costa, C., Vandermeers, F., Neelature Sriramareddy, S., Mascaux, C., Scherpereel, A., DUYSINX, B., LOUIS, R., DELVENNE, P., Hubert, P., & Willems, L. (01 February 2017). EGFR tyrosine kinase inhibitors overcome resistance to chemotherapy in malignant pleural mesothelioma [Poster presentation]. GIGA conference day: New insights into the hallmarks of cancer. |
Staumont, B. (20 May 2016). The role of TGF-alpha in the resistance to malignant pleural mesothelioma chemotherapy [Paper presentation]. GIGA-Cancer seminar. |
 | Hamaïdia, M., Staumont, B., Duysinx, B., Louis, R., & Willems, L. (2016). Improvement of malignant pleural mesothelioma immunotherapy by epigenetic modulators. Current Topics in Medicinal Chemistry, 16 (7). doi:10.2174/1568026615666150825141152 Peer Reviewed verified by ORBi |
 | Hamaïdia, M., Barez, P.-Y., Carpentier, A., Lebecque, S., Miazek, K., Paul, A., Neelature Sriramareddy, S., Staumont, B., Danthine, S., Deleu, M., Frederich, M., De Pauw, E., Delaplace, P., Delvigne, F., Goffin, D., Ongena, M., Duysinx, B., Louis, R., cosse, J.-P., & Willems, L. (2016). From Valeriana officinalis to cancer therapy: the success of a bio-sourced compound. Biotechnologie, Agronomie, Société et Environnement, 20 (S1), 314-320. Peer Reviewed verified by ORBi |
Staumont, B., Costa, C., Vandermeers, F., Neelature Sriramareddy, S., Mascaux, C., Scherpereel, A., DUYSINX, B., LOUIS, R., DELVENNE, P., Hubert, P., & Willems, L. (2016). EGFR tyrosine kinase inhibitors overcome resistance to chemotherapy in malignant pleural mesothelioma. In Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016. Peer reviewed |
 | Neelature Sriramareddy, S., Staumont, B., & Willems, L. (03 December 2015). Targeting cell cycle checkpoints and DNA damage response in Thyroid cancer [Poster presentation]. 28th Televie Seminar. |
 | Barez, P.-Y., De Brogniez, A., Carpentier, A., Gazon, H., Gillet, N., Gutiérrez, G., Hamaïdia, M., Jacques, J.-R., Perike, S., Neelature Sriramareddy, S., Renotte, N., Staumont, B., Reichert, M., Trono, K., & Willems, L. (24 November 2015). Recent advances in BLV research. Viruses, 7 (11), 6080-6088. doi:10.3390/v7112929 Peer Reviewed verified by ORBi |
 | Neelature Sriramareddy, S., Staumont, B., & Willems, L. (13 May 2015). Targeting cell cycle checkpoints and DNA damage response in Thyroid cancer [Paper presentation]. GIGA Cancer Day. |
Neelature Sriramareddy, S., Staumont, B., & Willems, L. (27 January 2015). Targeting cell cycle checkpoints and DNA damage response in Thyroid cancer [Poster presentation]. GIGA Day-Current Advances in Medical Genetics and Genomics. |
Staumont, B., Neelature Sriramareddy, S., & Willems, L. (27 January 2015). Targeting cell cycle checkpoints and DNA damage response in malignant pleural mesothelioma [Poster presentation]. GIGA conference day: Current advances in medical genetics and genomics. |
Staumont, B. (12 December 2014). DNA double-strand break repair pathway choice [Paper presentation]. GIGA-Cancer seminar. |
Staumont, B. (13 June 2014). Targeting cell cycle checkpoints and DNA damage response in malignant pleural mesothelioma [Paper presentation]. GIGA-Cancer seminar. |
 | Neelature Sriramareddy, S., Staumont, B., & Willems, L. (2014). DNA Damage and Thyroid Cancer. GIGADay-2014. |